Phase II trial of chemotherapy with temozolomide in combination with topotecan for central nervous system (CNS) metastases of solid tumors.

Trial Profile

Phase II trial of chemotherapy with temozolomide in combination with topotecan for central nervous system (CNS) metastases of solid tumors.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Temozolomide (Primary) ; Topotecan (Primary)
  • Indications Cancer metastases; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Sep 2017 Planned End Date changed from 1 Mar 2015 to 1 Nov 2014.
    • 15 Sep 2017 Planned primary completion date changed from 1 Mar 2015 to 1 Nov 2014.
    • 15 Sep 2017 Status changed from recruiting to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top